Ledger.Open graph →
SEC Form D · filed March 31, 2022

Incyclix Bio, LLC

Offering
$30.0M
Sold
$12.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
RESEARCH TRIANGLE PARK, NC
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (9)

Sid N. Subramony · Research Triangle Park, NCDirectorFredric N. Eshelman · Research Triangle Park, NCExec · DirectorPatrick N. Roberts · Research Triangle Park, NCExec · DirectorForrest D. Michael · Poole, United KingdomExec · DirectorParas Malde · George Town, Grand Cayman, Cayman IslandsExec · DirectorJohn .. Cogwill · Palo Alto, CADirectorSharon F. Knight · Cincinnati, OHExec · DirectorChris F. Kane · Cincinnati, OHExec · DirectorJohn Farris · NASHVILLE, TNDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗